Granite Investment Partners, LLC

Position in NEO — Neogenomics Inc

CIK 1542266 EL SEGUNDO, CA

Position in NEO

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$5,583,386

-$2,470,387 QoQ

Shares Held

752,478

+13.5% QoQ

Ownership

0.578%

of shares outstanding

% of Portfolio

0.36%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Granite Investment Partners, LLC holds $43,990,923 across 8 Diagnostics & Research names. NEO ranks #4 (12.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VCYT	Veracyte, Inc.	298,589	$9,617,551
2	GH	Guardant Health, Inc.	95,726	$8,842,210
3	ADPT	Adaptive Biotechnologies Corp	500,061	$6,940,846
4	NEO	Neogenomics Inc This page	752,478	$5,583,386
5	TMO	Thermo Fisher Scientific Inc.	11,098	$5,454,999
6	DHR	Danaher Corp /De/	26,604	$5,044,118
7	IDXX	Idexx Laboratories Inc /De	3,718	$2,089,107
8	WAT	Waters Corp /De/	1,406	$418,706

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,583,386	752,478	+13.5%	Shares	Sole	2026-04-30
2022-03-31	$8,053,773	662,862	-31.2%	Shares	Sole	2022-05-02
2021-12-31	$32,863,940	963,187	+6.9%	Shares	Sole	2022-02-10
2021-09-30	$43,450,732	900,720	-3.1%	Shares	Sole	2021-11-03
2021-06-30	$41,989,309	929,584	+0.3%	Shares	Sole	2021-07-30
2021-03-31	$44,698,406	926,776	-3.4%	Shares	Sole	2021-05-13
2020-12-31	$51,668,740	959,672	-2.8%	Shares	Sole	2021-02-12
2020-09-30	$36,418,435	987,217	-1.2%	Shares	Sole	2020-11-06
2020-06-30	$30,952,458	999,111	+0.3%	Shares	Sole	2020-08-03
2020-03-31	$27,495,556	995,855	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.